Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
3SBio and TLC Form Exclusive Partnership to Commercialize Two NanoX(TM) Products in Mainland China 2019-03-04 07:00
New Data Affirms Strength of UCB Immuno-Dermatology Portfolio 2019-03-01 20:56
Galderma: New Data Reveals Benefits of Combining Oral and Topical Treatment in Patients With Severe Papulopustular Rosacea 2019-03-01 20:33
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the NMPA 2019-03-01 18:00
Rakuten Aspyrian Announces Name Change to Rakuten Medical 2019-03-01 14:10
Pius S. Hornstein, PhD, Appointed New Country Chair of Sanofi China 2019-03-01 10:07
Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors 2019-03-01 07:15
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA 2019-02-28 09:52
First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma 2019-02-28 08:30
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards 2019-02-27 12:00
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
Top 3 Growth Opportunities for Digital Pathology-enabling Technology Companies 2019-02-26 03:13
Mallinckrodt Announces Extracorporeal Photopheresis (ECP) Research Collaboration Agreement With Transimmune AG 2019-02-25 22:00
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results 2019-02-25 21:00
Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing 2019-02-22 15:02
PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU 2019-02-22 06:13
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer 2019-02-21 18:30
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
1 333 334 335 336 337 410